Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Eisai and TorreyPines collaborate on Alzheimer's drug development

March 24, 2005

AstraZeneca discloses JNK3 inhibitors

March 23, 2005

New treatments for psychotic disorders described in patent literature

March 23, 2005

Teva issues reassurance on safety of Copaxone

March 23, 2005

Combunox launched

March 23, 2005

First clinical evidence for the benefits of R-pramipexole in ALS

March 22, 2005

Serono identifies 80 genes involved in MS

March 22, 2005

Positive results from pilot PK study of ondansetron lingual spray

March 22, 2005

Selective 5-HT6 receptor antagonist improves memory acquisition in rats / News in Context

March 22, 2005

NP-0361 shows promise in the treatment of Alzheimer's

March 22, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...